Yale Comprehensive Cancer Center

Yale Comprehensive Cancer Center

“Best Hospitals” national cancer-care rank: 29

“Best Hospitals” cancer-care score: 59.3/100

Founded: 1974

Beds: 168

Clinicians/researchers: 350




Research focus: 

Molecular origins of cancer, and targeted treatments.


Clinic at-a-glance:

Yale Cancer Center was launched as a result of collaboration between nationally and internationally renowned scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital at Yale-New Haven. This partnership enables the center to offer top-tier approaches for prevention, detection, diagnosis and treatment of cancer. This is Connecticut’s only National Cancer Institute-designated comprehensive cancer center and is recognized as a leader in the use of innovative tumor profiling techniques to develop personalized care plans for each patient. Specialty services include survivorship care, social work, prevention education, support groups, cancer boutique, exercise and nutrition support, therapeutic massage, relaxation imagery, Reiki touch, yoga, pet visitation and art expression. The center invests heavily in interdisciplinary cancer research that embraces basic science and translational research. The center boasts a number of research achievements, such as development of the first FDA-approved selective immunotherapy cancer treatment. Research programs include developmental therapeutics, cancer genetics and genomics, cancer immunology, molecular virology, cancer prevention and control, radiobiology and radiotherapy, and signal transduction.